Thank you for your response as more people participate in the discussions we are able to learn more from everyone, All I said is that Noxopharm is closer to commercialisation than RAC, but this is not reflected in Noxopharm share price.
Ann: March 2022 Quarterly Activities Report and Appendix 4C, page-39
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $3.404K | 32.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17322 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 55868 | 2 |
View Market Depth
| Last trade - 15.03pm 15/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |